|
| Status |
Public on Sep 01, 2017 |
| Title |
The BTK Inhibitor CC-292 shows activity in Mantle Cell Lymphoma and synergizes with Lenalidomide and NIK Inhibitors depending on NFκB mutational status |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
Mantle Cell lymphoma (MCL) were treated with the BTK inhibitor 1mM CC-292 for 48h
We used microarrays to uncover the mechanisms underlying CC-292 activity in Mantle Cell lymphoma (MCL)
|
| |
|
| Overall design |
Global RNA expression was done in two MCL cell lines treated in vitro with CC-292 for 48h
|
| |
|
| Contributor(s) |
Vidal-Crespo A, Pérez-Galán P |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Jan 31, 2017 |
| Last update date |
Mar 21, 2019 |
| Contact name |
Patricia Pérez-Galán |
| E-mail(s) |
[email protected]
|
| Phone |
932275400
|
| Organization name |
IDIBAPS
|
| Department |
Hemato-oncology
|
| Street address |
Centre Esther Koplowitz, Hemato-oncology dept, Rosello 149-153, 2nd floor
|
| City |
Barcelona |
| State/province |
Barcelona |
| ZIP/Postal code |
08036 |
| Country |
Spain |
| |
|
| Platforms (1) |
| GPL13667 |
[HG-U219] Affymetrix Human Genome U219 Array |
|
| Samples (4)
|
|
| Relations |
| BioProject |
PRJNA369382 |
Less...
More...